Ken Keller — SPARQNOW

At-a-Glance

President & CEO of Daiichi Sankyo, Inc. and Global Head of the Daiichi Sankyo Oncology Business
Chairman of the Board, President and CEO and Head of the Global Oncology Business Unit at Daiichi Sankyo Us
President and CEO at American Regent, Inc.
Executive Vice President and Chief Operating Officer at Spectrum Pharmaceuticals, Inc.
CEO Council Member at Wsj Leadership Institute

Biography

Ken Keller serves as the President & CEO of Daiichi Sankyo, Inc. and is the Global Head of the Daiichi Sankyo Oncology Business. In this capacity, he focuses on creating new standards of care and advancing medicine.

Prior to his current roles, Keller held significant leadership positions within the pharmaceutical industry. He was the Chairman of the Board, President and CEO, and Head of the Global Oncology Business Unit at Daiichi Sankyo US.